AusPAR: Adalimumab

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

12 April 2017
AusPAR Details
AusPAR
AusPAR Adalimumab (pdf, 1023 KB)
AusPAR Adalimumab (docx, 1 MB)
Attachment: Product Information Adalimumab (pdf, 643 KB)
Attachment: Product Information Adalimumab (docx, 388 KB)
Attachment: Extract from Clinical Evaluation Report: Adalimumab (pdf, 3 MB)
Attachment: Extract from Clinical Evaluation Report: Adalimumab (docx, 5 MB)
Active Ingredient
Adalimumab
Product Name
Humira
Sponsor
AbbVie Pty Ltd
Submission Number
PM-2015-01149-1-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
20 March 2017
Publication Date

12 April 2017
Category: 
Prescription medicines
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/753850